CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Hold” from the eighteen research firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating on the company. The […]
ARK Investment Management LLC cut its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,163,118 shares of the company’s stock after selling 175,329 shares during the quarter. CRISPR […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus recommendation of “Hold” from the eighteen brokerages that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company. The average […]
ARK Investment Management LLC lowered its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,163,118 shares of the company’s stock after selling 175,329 shares during the period. […]